Einsof Biohealth™ is a biotechnology company founded in 2012, though its origins go five years back in time. The company was started with a small R&D team with the mandate to improve the taste, speed, and safeness of rehydration drinks, particularly pediatric ones such as Oral Rehydration Solutions.
Based on proprietary technology, the R&D team came up with a solution: An Encapsulated Nano-Electrolyte™. Encapsulated salty ingredients become tasteless and thus was able to be significantly improved.
The R&D team grew in size, as did the large pipeline of new products with significantly superior performance to existing in-market options.
Our headquarter office is in Miami, Florida and we have a separate R&D location. Our products are manufactured by top GMO facilities, and they are closely supervised by our team of experts.
As with every beginning, we have our own story. It all began with a concerned and highly frustrated father, our founder, whose adorable young boy was experiencing an awful episode of diarrhea. Unlike most fathers, he was an expert in the pharmaceutical industry and was perfectly aware that at his front door there was case of a mild dehydration quickly turning into a moderate one. Highly knowledgeable of its dangers, he felt helpless: water and regular drinks could only worsen the situation; sport and juice drinks were inappropriate; pediatric drinks such as Pedialyte were the only right option, but his son didn't like its taste and constantly rejected it.
"Good taste!... That's all we need", he thought while he was watching vividly how the diarrhea and consequently the dehydration were consuming his little two-year-old son.
After almost five years, he ran into the right scientist to finally connect the dots between the delivery system existing in some oncology drugs and the means to superior taste and rehydration and that's how our 'Encapsulated Nano-Electrolytes™' technology was born.
Our product was originally developed for pediatric use, as dehydration is a devastating threat and the number one cause of death worldwide in children under five years old. Along the way, the product performed extremely well with patients suffering from short bowel syndrome, cyclical vomiting syndrome, hypoxemia, and Sjogren's syndrome, as well as with the elderly population, amongst other cases with regular and recurrent ER visits for IV therapy.
A team of PhD’s and passionate science experts in biotechnology conduct all research and product development. They are at the cutting edge of new technological advances on the category and oversee everything from products and technologies’ early assessment, to prototypes, clinical trials, and FDA compliance, in addition to journal publications.
Advisors and Investors
Einsof Biohealth™ is a privately owned company founded primarily by one investor with vast pharmaceutical background and experience in the nutritional business. The company is self-funded by a group of large and minor investors. The company also benefits from a diverse group of experts and seasoned advisors.